Both tirzepatide and retatrutide are commonly paired with B12, glycine, and other compounds in formulations designed to offset potential nutrient depletion from reduced food intake
Subsequently, adding a GLP1-RA can enhance cardiovascular protection and further renal benefits, particularly in patients with high cardiovascular risk or significant albuminuria
Aggressive titration protocol (not recommended) Some people attempt to reach high doses quickly by starting at 4 mg or skipping dose levels entirely
The dual GLP-1/GIP mechanism clearly outperformed single-agonist semaglutide
After 48 weeks, the 4 mg retatrutide group led to weight reductions of more than 5%, 10%, and 15% in 92%, 75%, and 60% of participants, respectively
over half expect GLP-1 growth to more than triple